541 related articles for article (PubMed ID: 30058050)
1. Effectiveness of multiple botulinum toxin sessions and the duration of effects in spasticity therapy in children with cerebral palsy.
Mirska A; Kułak W; Okurowska-Zawada B; Dmitruk E
Childs Nerv Syst; 2019 Jan; 35(1):141-147. PubMed ID: 30058050
[TBL] [Abstract][Full Text] [Related]
2. Use of botulinum toxin in the treatment of ankle plantar flexor spasticity in children with cerebral palsy.
Mirska A; Cybula K; Okurowska-Zawada B; Kułak W; Dmitruk E; Okulczyk K; Kalinowska AK
J Pediatr Orthop B; 2014 Nov; 23(6):517-22. PubMed ID: 25171568
[TBL] [Abstract][Full Text] [Related]
3. Botulinum toxin A injection for spasticity in diplegic-type cerebral palsy.
El O; Peker O; Kosay C; Iyilikci L; Bozan O; Berk H
J Child Neurol; 2006 Dec; 21(12):1009-12. PubMed ID: 17156689
[TBL] [Abstract][Full Text] [Related]
4. Effects of ultrasound-guided botulinum toxin type-A injections with a specific approach in spastic cerebral palsy.
Büyükavcı R; Büyükavcı MA
Acta Neurol Belg; 2018 Sep; 118(3):429-433. PubMed ID: 29694645
[TBL] [Abstract][Full Text] [Related]
5. Effects of botulinum toxin A therapy with electrical stimulation on spastic calf muscles in children with cerebral palsy.
Kang BS; Bang MS; Jung SH
Am J Phys Med Rehabil; 2007 Nov; 86(11):901-6. PubMed ID: 17873826
[TBL] [Abstract][Full Text] [Related]
6. Quantitative evaluation for spasticity of calf muscle after botulinum toxin injection in patients with cerebral palsy: a pilot study.
Lin YC; Lin IL; Chou TF; Lee HM
J Neuroeng Rehabil; 2016 Mar; 13():25. PubMed ID: 26969526
[TBL] [Abstract][Full Text] [Related]
7. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
Lukban MB; Rosales RL; Dressler D
J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of Multilevel Botulinum Toxin A Injection with Integrated Treatment Program on Spasticity Reduction in Non-Ambulatory Young Children with Cerebral Palsy.
Aydil S; Akpinar FM; Akpinar E; Beng K; Yagmurlu MF
Med Princ Pract; 2019; 28(4):309-314. PubMed ID: 30840957
[TBL] [Abstract][Full Text] [Related]
9. Botulinum Toxin Type A Injection for Spastic Equinovarus Foot in Children with Spastic Cerebral Palsy: Effects on Gait and Foot Pressure Distribution.
Choi JY; Jung S; Rha DW; Park ES
Yonsei Med J; 2016 Mar; 57(2):496-504. PubMed ID: 26847306
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy.
Hawamdeh ZM; Ibrahim AI; Al-Qudah AA
Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388
[TBL] [Abstract][Full Text] [Related]
11. Combining strength training and botulinum neurotoxin intervention in children with cerebral palsy: the impact on muscle morphology and strength.
Williams SA; Elliott C; Valentine J; Gubbay A; Shipman P; Reid S
Disabil Rehabil; 2013 Apr; 35(7):596-605. PubMed ID: 22928803
[TBL] [Abstract][Full Text] [Related]
12. Long-term effects of botulinum toxin A in children with cerebral palsy.
Tedroff K; Granath F; Forssberg H; Haglund-Akerlind Y
Dev Med Child Neurol; 2009 Feb; 51(2):120-7. PubMed ID: 19191845
[TBL] [Abstract][Full Text] [Related]
13. Botulinum toxin type A injection increases range of motion in hip, knee and ankle joint contractures of children with cerebral palsy.
Aktaş E; Ömeroğlu H
Eklem Hastalik Cerrahisi; 2019 Aug; 30(2):155-62. PubMed ID: 31291865
[TBL] [Abstract][Full Text] [Related]
14. Treating spastic equinus foot from cerebral palsy with botulinum toxin type A: what factors influence the results?: an analysis of 189 consecutive cases.
Pascual-Pascual SI; Pascual-Castroviejo I; Ruiz PJ
Am J Phys Med Rehabil; 2011 Jul; 90(7):554-63. PubMed ID: 21765274
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of botulinum toxin A therapy in children with adductor spasm by gross motor function measure.
Mall V; Heinen F; Kirschner J; Linder M; Stein S; Michaelis U; Bernius P; Lane M; Korinthenberg R
J Child Neurol; 2000 Apr; 15(4):214-7. PubMed ID: 10805185
[TBL] [Abstract][Full Text] [Related]
16. Factors predicting the efficacy of botulinum toxin-A treatment of the lower limb in children with cerebral palsy.
Fazzi E; Maraucci I; Torrielli S; Motta F; Lanzi G
J Child Neurol; 2005 Aug; 20(8):661-6. PubMed ID: 16225811
[TBL] [Abstract][Full Text] [Related]
17. Botulinum toxin type A in the treatment of lower-limb spasticity in children with cerebral palsy.
Camargo CH; Teive HA; Zonta M; Silva GC; Oliveira MR; Roriz MM; Brandi IV; Becker N; Scola RH; Werneck LC
Arq Neuropsiquiatr; 2009 Mar; 67(1):62-8. PubMed ID: 19330214
[TBL] [Abstract][Full Text] [Related]
18. Change of dynamic gastrocnemius and soleus muscle length after block of spastic calf muscle in cerebral palsy.
Bang MS; Chung SG; Kim SB; Kim SJ
Am J Phys Med Rehabil; 2002 Oct; 81(10):760-4. PubMed ID: 12362116
[TBL] [Abstract][Full Text] [Related]
19. The effect of botulinum toxin type A injection into the gastrocnemius muscle on sit-to-stand transfer in children with spastic diplegic cerebral palsy.
Park ES; Park CI; Chang HC; Park CW; Lee DS
Clin Rehabil; 2006 Aug; 20(8):668-74. PubMed ID: 16944824
[TBL] [Abstract][Full Text] [Related]
20. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy.
Kay RM; Rethlefsen SA; Fern-Buneo A; Wren TA; Skaggs DL
J Bone Joint Surg Am; 2004 Nov; 86(11):2377-84. PubMed ID: 15523006
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
